The Five Taleb Lessons That Shape Schwar Capital
Investing in a world you cannot predict
To read our full disclaimer, click here.
If I had to throw out every investing book on my shelf and keep the work of one author, it would be Nassim Nicholas Taleb.
Not because he gives stock tips - he doesn’t. Not because he predicts markets - he refuses to. But because he answers a question almost no one else in finance even asks:
How do you survive a world you cannot predict?
Over the years I’ve come back to his ideas more than any others. They’ve shaped how I size positions, how I think about leverage, how I read research, and - perhaps most importantly - whose advice I take seriously.
This post is a distillation. The five Taleb lessons that, more than any others, sit underneath how I run Schwar Capital.
1. Antifragility
The opposite of fragile is not robust. It is antifragile.
This is Taleb’s most original idea, and the one most of the industry has failed to absorb. Robust things merely survive stress. Antifragile things actually gain from it.
Your muscles get stronger from strain. Your immune system gets better from exposure. Ideas get sharper under attack. None of these things are simply surviving disorder - they are improving because of it.
Markets are full of fragility dressed up as sophistication. Leverage. Tightly coupled portfolios. Hedging strategies that work until correlations break. Optimised allocations that depend on the next five years looking like the last five. All of them quietly fall apart in the conditions where it matters most to hold together.
The right question is not “will this survive a crisis?” The right question is “will this benefit from one?”
In practice, antifragility means owning things that gain from volatility rather than just endure it. A cash buffer becomes more valuable when markets crash, not less. A concentrated portfolio of high-quality businesses bought at fair prices benefits from sell-offs, because they let you add to them. A simple structure with low costs and no leverage compounds quietly while complex ones spend every crisis defending themselves.
Fragile portfolios fear volatility. Robust portfolios tolerate it. Antifragile portfolios feed on it.
The goal at Schwar Capital is the third.
2. The Barbell Strategy
Most people try to find the “sensible middle.” Taleb argues that middle is where the fragile live - and die.
The barbell is one of the most counter-intuitive ideas in modern finance, and one of the most powerful. Instead of taking moderate risk across a portfolio, you split it into two extremes:
The vast majority - cash, short-duration treasuries, the safest assets you can find.
A small minority - highly asymmetric bets where the upside is uncapped and the downside is capped at what you put in.
You hold nothing in the middle.
The mathematics are quietly devastating. A portfolio of “moderate risk” investments looks reasonable on a spreadsheet but tends to lose a great deal in a crisis and gain modestly the rest of the time. A barbell loses almost nothing on the safe side, and the speculative side - precisely because each position is small - cannot ruin you, but any one of them can transform you.
This is why I obsess over downside before upside. The safe side of the barbell is what allows the asymmetric side to exist. Without preservation, there is no aggression - only ruin.
3. Via Negativa
Most investing improvement comes from removal, not addition.
Taleb borrows the term Via Negativa from theology, but its application in markets is almost embarrassingly direct: you don’t get rich by chasing returns; you get rich by avoiding ruin.
What separates good investors from great ones is almost never something they did. It’s something they refused to do.
They refused to use leverage. They refused to buy the obvious bubble. They refused to invest in things they didn’t understand. They refused to add a position because they were bored. They refused to act on a forecast they had no business making.
This is harder than it sounds. Every part of the industry is pointed in the opposite direction. More ideas. More data. More trades. More indicators. Activity is mistaken for skill; complexity is mistaken for sophistication.
My own checklist is shorter every year, not longer. Quality of business, ownership, balance sheet, valuation, fragility. If a thesis cannot survive contact with five questions, no twentieth question is going to save it.
The hardest word to say in markets is no. It is also the most profitable.
💡 Finding this valuable? Share it with someone who’d benefit.
4. The Lindy Effect
For things that don’t age - ideas, books, technologies, businesses - the best predictor of how long something will last is how long it has already lasted.
A book that has been read for two thousand years will probably be read for another two thousand. A book published last Tuesday probably will not. A business model that has survived multiple recessions, technology shifts, and regulatory regimes is telling you something a five-year-old startup simply cannot.
Time is the only honest critic, and it cannot be faked.
This shapes how I evaluate businesses. I have a strong bias toward what has already worked - durable demand, repeat purchase, products that customers have been buying for decades without thinking. The boring industries that have outlasted every wave of disruption are usually boring for the same reason they’re durable: they meet a need that was real fifty years ago and will be real fifty years from now.
It also shapes how I read. I would rather re-read Graham, Buffett’s letters, Marks, Taleb, and Munger than chase the latest book of the month. The signal density is higher. The ideas have already been tested by something more rigorous than any peer review: time.
If an idea has not been around long enough to fail, it has not been around long enough to be trusted.
5. The Turkey Problem
The greatest risks are never in the data. They are in the assumption that the data is all there is.
Taleb tells a parable. Every day for a thousand days, a turkey is fed by the farmer. With each passing day the turkey’s confidence in the farmer’s benevolence grows. The data is unambiguous. The trend is up and to the right. The model fits beautifully.
On day 1,001 - the day before Thanksgiving - the turkey’s confidence in his model is at its highest, and his model has never been more wrong.
Every financial crisis I have studied has a turkey in it. Housing prices have never fallen nationally. Volatility is structurally lower now. This bank is too big to fail. Rates can’t go higher than 1%. The longer something has been true, the more confident the consensus, the more dangerous the eventual reversal.
The defence is not to predict the day of reckoning. No one can. The defence is to never let your portfolio be a turkey - to never construct a strategy that requires the past pattern to keep holding in order to survive.
This is why I refuse leverage, why I keep a cash buffer, why I prefer businesses that have already survived a downturn, and why I distrust any model whose track record is short and whose conditions have been benign.
Survival first. Returns second. Always.
Conclusion
If you read Taleb long enough, a single theme emerges underneath all of his work. It is not that markets are dangerous - though they are. It is not that experts are often wrong - though they are. It is something deeper:
The world is fundamentally more uncertain than the people running it want you to believe.
Most of finance is a sophisticated machine for ignoring this fact. Models, forecasts, ratings, projections - all designed to give the appearance of control over something that has none.
The five lessons above are, in different ways, the same lesson:
Stop trying to predict the world. Start trying to survive it. The compounding will take care of itself.
That belief sits underneath every position in the Schwar Capital portfolio, every research note I write, and every investment decision I make.
Dom Schwar Capital
Dom
Schwar Capital
Disclaimer: The content provided in this newsletter is for informational purposes only and does not constitute financial, investment, or other professional advice. The opinions expressed here are those of the author and do not necessarily reflect the views of Schwar Capital. Investing involves risk, including the possible loss of principal. Past performance is not indicative of future results. The author may or may not hold positions in the stocks or other financial instruments mentioned. Always do your own research or consult with a qualified financial advisor before making any investment decisions. You can see our full disclaimer here.